Skip to playerSkip to main contentSkip to footer
ABC NEWS (Australia)
  • 10/13/2021
Around the world, COVID vaccines are working well to reduce rates of severe disease and death. But some studies suggest their ability to protect people from milder illness and asymptomatic infections is waning with time.

Category

📺
TV

Recommended

1:41
Up next
COVID-19 vaccines — a lot left to do
DW (English)
0:38
Scientists Want To Repurpose Polio Vaccine To Battle COVID-19
Wochit
1:43
What You Need To Know About The New Coronavirus Vaccine
Viraly-Stories
1:10
Researchers identify targets for COVID-19 vaccine using cancer immunotherapy tools
Deccan Herald
1:03
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis
RenubResearch
1:55
FUN-MOOC : Vaccinology session 3
france-universite-numerique
2:41
COVID-19 vaccine to become fastest made in history; nine candidates in final stage of trials
Arirang News
2:44
Australian-led research makes flu vaccine discovery
ABC NEWS (Australia)
3:20
Kent expert says testing and vaccine sites are needed to curb coronavirus spread
KentOnline / KMTV
2:16
Oxford's COVID-19 vaccine shows promising immune response in human trials
Arirang News
5:29
Results from largest study into COVID vaccine side effects released
ABC NEWS (Australia)
7:03
All you need to know about COVID-19 vaccine for children
Aaj Tak
1:53
World's largest study of COVID-19 vaccine side effects
Australian Community Media
0:32
Flu Vaccine May Lower Risk Of Severe Illness From COVID-19
Wochit Entertainment
1:55
Parents of toddler who died from meningococcal disease campaign for childhood immunisation amid vaccine hesitancy
ABC NEWS (Australia)
0:52
FDA approves first-ever vaccine to combat severe RSV
Benzinga
1:23
25 Million Kids Missed Routine Vaccinations Because Of COVID-19: United Nations
The Indian Express
2:54
Calls for clearer communication on AstraZeneca vaccine
ABC NEWS (Australia)
2:07
Elderly, frontline workers should be vaccinated first: AIIMS Director
Deccan Herald
3:11
Covaxin Phase 3 Interim Trial Data: Results Show 81% Efficacy Rate, Claims Bharat Biotech
LatestLY
1:25
Will We Need to Vaccine Against Covid-19 More Than Once? 
Viraly-Stories
2:14
Pfizer-BioNTech COVID-19 vaccine shows 90% efficacy for kids aged 5 to 11 – FDA
Manila Bulletin
2:13
Only 2~3% of recovered patients generate antibody for COVID-19: Research
Arirang News
2:55
US CDC Guidelines For Those Fully Vaccinated Against COVID-19: Here Is What You Can & Cannot Do After Getting A COVID-19 Vaccine
LatestLY
2:11
U.S. prepares to roll out child vaccines
23ABC News